CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, July 29th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...